Tsingke Showcases at AACR 2025 -- Advancing Global Cancer Research with Integrated Synthesis Solutions
Comunicato Precedente
Comunicato Successivo
What Tsingke Offers for Oncology Research
Building a Global Synthesis Engine for Cancer Innovation
Tsingke is committed to enabling biotech companies, CDMOs, and academic researchers with a one-stop synthesis platform—from molecular design and synthesis to expression and functional validation. By supporting critical steps in target discovery, validation, and preclinical development, we help accelerate the path from lab to clinic.
Interested in learning more or discussing a custom solution?
Reach out to us at [email protected] or visit www.tsingke.com
View original content:https://www.prnewswire.co.uk/news-releases/tsingke-showcases-at-aacr-2025--advancing-global-cancer-research-with-integrated-synthesis-solutions-302456314.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




